ArticleCureus2025

A Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for Cytomegalovirus (CMV) Prophylaxis in High-Risk Kidney Transplant Recipients: Study Protocol.

Hannah Culpepper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.